A bold early-stage project aiming to develop lab-grown lungs—which could bring fresh hope to people with pulmonary diseases such as asthma and lung cancer—has been awarded $1.5 million over three years from the Paul G. Allen Frontiers Group. The effort will be led by researchers at Boston University’s College of Engineering and School of Medicine.
Air-liquid interface culture promotes maturation and allows environmental exposure of pluripotent stem cell–derived alveolar epithelium
Type 2 alveolar epithelial cells (AT2s), facultative progenitor cells of the lung alveolus, play a
